|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash and cash equivalents | |||||||||
| Total Current Assets | |||||||||
| Other Assets | |||||||||
| Intangible Assets, net | |||||||||
| Total Other Current Assets | |||||||||
| Prepaid Expense and Other Assets | |||||||||
| Prepaid Expense, Current | |||||||||
| Prepaid expenses | |||||||||
| Total Other Assets | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES & STOCKHOLDERS’ EQUITY | |||||||||
| Liabilities | |||||||||
| Accounts Payable | |||||||||
| Deferred revenue | |||||||||
| Loan from Related Parties | |||||||||
| Deposit for Common Stock | |||||||||
| Total Current Liabilities | |||||||||
| Total Liabilities | |||||||||
| Stockholders’ Equity | |||||||||
| Common Stock, $0.001 par value, 75,000,000 shares authorized, 4,044,334 shares issued and outstanding as of June 30, 2026 and 5,044,334 as of September 30, 2025 | |||||||||
| Additional Paid-in Capital | |||||||||
| Accumulated Deficit | |||||||||
| Total Stockholders’ Equity | |||||||||
| TOTAL LIABILITIES & STOCKHOLDER’S EQUITY |
Loading...
